Vitamin K2 MK-7 softgels and vitamin D3 and K2 capsules sold in Ireland by Probiotic.ie

Vitamin K2 in Ireland: Benefits, D3 + K2, MK-4 vs MK-7, Dosage and Safety

Evidence Guide · Vitamin K2 and D3 + K2 Ireland · November 2026

Vitamin K2 is now sold on its own and paired with vitamin D3 in most Irish pharmacies and health stores, usually with a confident story about bones and arteries. This guide separates what randomised trials have shown from what remains theory, explains the difference between MK-4 and MK-7, and sets out how to choose a vitamin K2 or D3 + K2 supplement in Ireland.

At a Glance

Vitamin K2 (menaquinone) is a fat-soluble vitamin found in natto, cheese and some animal foods, sold in Ireland as a food supplement under FSAI guidelines, not as a medicine. It carries two authorised EU health claims: it contributes to normal blood clotting and to the maintenance of normal bones. The strongest human evidence is a three-year randomised trial by Knapen et al. (Osteoporosis International, 2013, PMID 23525894) in which 180 µg/day of MK-7 reduced age-related bone loss in 244 postmenopausal women[1], but a second three-year trial by Rønn et al. (Osteoporosis International, 2021, PMID 33030563) found no bone density benefit from 375 µg/day MK-7 in 142 women with osteopenia[18], so the bone evidence is mixed. What is not proven: no MK-7 trial has measured fractures or heart attacks, and the 2022 AVADEC trial (Circulation, PMID 35465686) found 720 µg MK-7 plus vitamin D did not slow existing calcification versus placebo[3]. The HSE advises people aged 13 to 64 in Ireland to take 15 µg (600 IU) vitamin D daily from 31 October to 17 March, year-round for specified groups, and adults aged 65 and over to take it all year[13], which is why D3 + K2 combinations are popular in winter. Probiotic.ie stocks Healthy Origins Vitamin K2 MK-7 100 µg, Jarrow Formulas MK-7 90 µg and NOW Vitamin D3 & K2, shipped from Dublin with nationwide delivery.

Who This Guide Is For
  • Adults in Ireland deciding whether to add vitamin K2 to a vitamin D3 supplement this winter
  • Anyone comparing MK-4 and MK-7 forms, or trying to read a D3 + K2 label
  • Postmenopausal women looking for the actual trial evidence on K2 and bone
  • People on anticoagulants who need to know why vitamin K2 is a medication issue
  • Not for: anyone seeking treatment for osteoporosis or heart disease. Those are GP conversations, not supplement decisions.

Vitamin K2 (menaquinone) definition: Vitamin K2 is the family of menaquinones (MK-4 to MK-13), a fat-soluble form of vitamin K produced by bacteria and found in fermented foods such as natto and cheese and, as MK-4, in animal tissues, where it acts as a cofactor for the enzyme that activates vitamin K-dependent proteins in liver, bone and blood vessel walls.

What is a vitamin K2 or D3 + K2 supplement in Ireland?

A vitamin K2 supplement in Ireland is a food supplement providing menaquinone, usually MK-7 from fermented natto (90 to 200 µg) or MK-4 (typically 45 µg), sold as softgels or capsules under FSAI food supplement rules. A D3 + K2 supplement combines it with cholecalciferol, most often 25 µg (1,000 IU) to 125 µg (5,000 IU). It is not a medicine and is not a treatment for osteoporosis, arterial calcification or heart disease. The human evidence for MK-7 and bone density is mixed: 180 µg/day slowed bone loss over three years in one trial (Knapen et al., 2013, PMID 23525894)[1] and 375 µg/day did not in another (Rønn et al., 2021, PMID 33030563)[18], and the added value of combining K2 with D3 over D3 alone has not been tested in a human outcome trial. Probiotic.ie sells Healthy Origins K2 MK-7 100 µg, Jarrow Formulas MK-7 90 µg and NOW D3 & K2 with delivery from Dublin across Ireland.

In a hurry? The quick picks
MK-7 from natto, 6-month supplyHealthy Origins Vitamin K2 as MK-7 100 µg180 softgels · 1 daily · olive oil base · vegetarian softgel
Price on product page
✓ Buy →
MK-7, smaller pack to trialJarrow Formulas Vitamin K2 MK-7 90 µg60 softgels · VitaMK7® fermented natto source · gelatin softgel
Price on product page
View →
D3 and K2 in one capsuleNOW Vitamin D3 & K2 1,000 IU / 45 µg120 veg capsules · 25 µg D3 + 45 µg K2 as MK-4 · vegetarian
Price on product page
View →
High-strength D3 with three K formsLife Extension Vitamins D and K with Sea-Iodine60 capsules · 125 µg (5,000 IU) D3 · K1 + MK-4 + MK-7 · 1,000 µg iodine · check with GP first
Price on product page
View →
Compare the full vitamin K2 MK-7 range at Probiotic.ie →
Fast Facts — Vitamin K2
  • What it is: The menaquinone family of vitamin K (MK-4 to MK-13); MK-7 and MK-4 are the forms used in supplements
  • Where found in the body: Liver (clotting factors), bone (osteocalcin) and blood vessel walls (matrix Gla protein); MK-7 circulates for days, K1 for hours[5]
  • Dietary sources: Natto (MK-7, by far the richest), cheese and other fermented dairy, egg yolk, butter, liver; green vegetables supply K1, not K2[14]
  • Supplement source: MK-7 is usually fermented from Bacillus subtilis natto (vegan-origin ingredient); MK-4 is typically synthetic
  • Regulatory intake figures: EFSA adequate intake for vitamin K is 70 µg/day for adults (EFSA Journal, 2017); EFSA has set no upper intake level for vitamin K; the HSE says 1 mg/day or less from supplements is unlikely to cause harm[12]
  • Typical trial dose (MK-7): 90 to 360 µg/day; the three-year bone and arterial trials used 180 µg/day[1]
  • Vitamin D companion figures: HSE advises 15 µg (600 IU) daily in winter for adults; EFSA tolerable upper intake level is 100 µg (4,000 IU)/day[11]
  • Is it a blood thinner or a blood thickener? Neither. Vitamin K is needed for normal clotting; supplements do not thicken blood in healthy people, but they do reduce the effect of warfarin
  • Vegetarian/vegan suitable? Depends on the capsule: Healthy Origins uses a vegetarian softgel, NOW uses a hypromellose capsule, Jarrow uses bovine gelatin
  • Irish regulatory status: Food supplement under FSAI guidelines, not a medicine
  • Irish VAT rate on supplements: 13.5%
What Vitamin K2 Is Not
  • Vitamin K2 is not a treatment for osteoporosis; no MK-7 trial has measured fractures, and the fracture trials that exist used pharmacological MK-4 at 45 mg/day in Japan, not retail doses
  • Vitamin K2 is not proven to reverse or slow existing arterial or heart valve calcification in humans; a large randomised trial (AVADEC, 2022) found no effect versus placebo
  • Vitamin K2 is not the same as vitamin K1 from green vegetables, and MK-4 is not interchangeable with MK-7 at the same microgram dose
  • Vitamin K2 is not a mandatory partner for vitamin D3; D3 works with or without it
  • Vitamin K2 is not a blood thinner, and it is not safe to start on warfarin without medical advice
  • Vitamin K2 is not a medicine in Ireland; it is a food supplement
Evidence Summary

What is well-supported: MK-7 at 90 µg/day and above reliably improves vitamin K status markers (carboxylated osteocalcin and matrix Gla protein) within weeks (Theuwissen et al., British Journal of Nutrition, 2012, PMID 22289649), and in the three-year Maastricht University trial (Knapen et al., Osteoporosis International, 2013, PMID 23525894) 180 µg/day reduced age-related bone loss at the lumbar spine and femoral neck in 244 postmenopausal women.

What is not proven: Long-term MK-7 trials have produced mixed bone density results: Rønn et al. (2021, PMID 33030563) found no benefit over three years at 375 µg/day and Emaus et al. (2010, PMID 19937427) none over one year at 360 µg/day. No MK-7 trial has measured fractures or cardiovascular events, and AVADEC (Circulation, 2022, PMID 35465686) found no slowing of calcification with MK-7 plus vitamin D versus placebo. Better biomarkers have not consistently translated into better bone.

Research dose range (not a recommended intake): MK-7 trials used 90 to 375 µg/day, most often 180 µg/day; there is no official Irish or EU recommended intake specific to K2. For vitamin D the HSE figure is 15 µg (600 IU)/day; the EFSA tolerable upper intake level of 100 µg (4,000 IU)/day is a ceiling, not a target.

Key safety note: Vitamin K2 opposes warfarin and other vitamin K antagonist anticoagulants. Do not start it on these medicines without your prescriber's agreement.

Feature Specification Evidence Level
Bone density (postmenopausal women) 180 to 375 µg/day MK-7, 1 to 3 years Mixed: one 3-year RCT positive, one 3-year RCT null, one 1-year RCT null
Arterial stiffness markers 180 µg/day MK-7, 3 years, n=244 Surrogate markers only; no event data
Calcification progression 720 µg/day MK-7 + 25 µg D3, 2 years, n=365 RCT null (AVADEC 2022)
Fracture reduction No MK-7 trial; MK-4 at 45 mg/day in Japanese trials Pharmacological MK-4 only; not tested at retail doses
Heart attack or stroke reduction No trial of any K2 form Not tested
Bioavailability MK-7 vs MK-4 Single 420 µg dose comparison MK-7 absorbed; MK-4 undetectable in serum
Safety at supplement doses Up to 720 µg/day for 2 years in RCT Adverse events same as placebo
Irish regulatory status Food supplement, FSAI, 13.5% VAT Permitted vitamin form; two authorised EU claims
Research Context — Not Product Claims

The clinical and mechanistic research discussed in this article relates to vitamin K2 and vitamin D3 as studied compounds at the doses and durations named. It should not be read as a claim that Healthy Origins Vitamin K2 MK-7, Jarrow Formulas MK-7 or NOW Vitamin D3 & K2 produce these effects. These products are food supplements, not medicines. The only health claims made for them are the authorised EU claims for vitamin K (normal blood clotting, maintenance of normal bones) and vitamin D (normal absorption of calcium and phosphorus, normal blood calcium levels, maintenance of normal bones, teeth and muscle function, normal immune function).

Healthy Origins Vitamin K2 as MK-7 100 µg · 180 Softgels

Menaquinone-7 fermented from natto in an organic extra virgin olive oil base. One softgel daily, six months per bottle.

100 µg MK-7 from natto 180 softgels Vegetarian softgel Non-GMO, gluten-free Ships from Dublin
✓ Buy Healthy Origins Vitamin K2 MK-7 →

Food supplement, not a medicine. Price shown on the product page includes 13.5% VAT. Tracked delivery across Ireland. Probiotic.ie is an authorised Irish retailer of Healthy Origins.

Definitions

What is vitamin K2? K1 vs K2, MK-4 vs MK-7

Vitamin K is a group of fat-soluble compounds that the body needs to activate a set of proteins through a chemical step called carboxylation. The HSE describes vitamin K as needed for blood clotting and wound healing, and notes some evidence that it may support bone health.[14]

Vitamin K1 (phylloquinone) is the plant form, found in green leafy vegetables, and makes up most of the vitamin K in an Irish diet. Vitamin K2 (menaquinones) is made by bacteria. The two supplement forms are MK-4, a short-chain menaquinone found in animal foods and usually made synthetically, and MK-7, a long-chain menaquinone fermented from natto.

The practical difference is how long each form stays in the blood. Schurgers and colleagues at Maastricht University (Blood, 2007, PMID 17158229) compared K1 and MK-7 in healthy volunteers and found MK-7 had a half-life of around three days against hours for K1, reached far higher steady-state levels and activated the bone protein osteocalcin more effectively at the same dose.[5]

MK-4 behaves differently again. Sato et al. (Nutrition Journal, 2012, PMID 23140417) gave healthy women a single 420 µg dose of either MK-4 or MK-7. MK-7 was well absorbed and raised serum levels; MK-4 was not detectable in serum at all.[6] This matters when reading a D3 + K2 label: 45 µg of MK-4 and 100 µg of MK-7 are not comparable doses.

Form Source Half-life in blood Trial doses with bone data Typical supplement dose
Vitamin K1 (phylloquinone) Green leafy vegetables, vegetable oils Hours[5] Up to 1,000 µg/day in older trials 75 to 1,000 µg
Vitamin K2 MK-4 (menaquinone-4) Animal foods; usually synthetic in supplements Short; undetectable after a 420 µg dose[6] 45 mg/day (Japanese pharmaceutical use) 45 to 1,000 µg
Vitamin K2 MK-7 (menaquinone-7) Natto; fermented from Bacillus subtilis natto About 3 days[5] 180 µg/day (3-year RCT); 360 µg/day (1-year RCT) 90 to 200 µg
The Pairing

Why vitamin D3 and K2 are taken together

The logic sold with the D3 + K2 pairing is simple: vitamin D increases how much calcium you absorb, and vitamin K activates the proteins that decide where that calcium goes. Each half of that sentence is backed by an authorised EU health claim. Vitamin D contributes to normal absorption and utilisation of calcium and phosphorus and to the maintenance of normal bones; vitamin K contributes to normal blood clotting and to the maintenance of normal bones.[15]

The claim that the two are better together is a different thing, and it has not been established in a human outcome trial. A large randomised trial of a D3 + K2 combination, AVADEC (Diederichsen et al., Circulation, 2022, PMID 35465686), gave 365 Danish men 720 µg MK-7 plus 25 µg vitamin D or placebo for two years and found no difference in calcification progression. Because AVADEC had no vitamin D-only arm, it cannot say whether adding K2 to D3 helps or not; it only says the combination did not beat placebo on calcification. The Rønn bone trial added MK-7 on top of vitamin D and calcium in both arms and found no extra bone density benefit over three years.[3] The positive Knapen bone trial used MK-7 alone, not a combination.

So the honest position is: taking K2 alongside D3 is reasonable and well tolerated, vitamin D3 has its own strong case in Ireland, and K2 has its own moderate case for bone in postmenopausal women. Treat the combination as two supplements that happen to share a capsule, not as a proven synergy. Our vitamin D3 Ireland guide covers the vitamin D side in depth, including deficiency rates and HSE dosing.

🦴 Osteocalcin activation

Vitamin K2 is the cofactor for carboxylating osteocalcin, the protein that binds calcium into bone matrix. MK-7 at 180 µg/day roughly halved inactive osteocalcin in three years.Evidence: human RCT biomarker (Knapen 2013)

🩸 Clotting factor activation

In the liver, vitamin K activates clotting factors II, VII, IX and X. This is the basis of the authorised blood clotting claim and the reason warfarin and vitamin K oppose each other.Evidence: established physiology; EU authorised claim

🫀 Matrix Gla protein

Matrix Gla protein (MGP) in vessel walls is proposed to inhibit calcium deposition once activated by vitamin K. MK-7 lowered inactive MGP by 50% in the 2015 Knapen trial, but AVADEC found no change in calcification.Evidence: human biomarker; outcome RCT null

☀️ Vitamin D and calcium absorption

Vitamin D is needed for normal intestinal absorption of calcium and phosphorus and for normal blood calcium levels. This is the mechanistic reason D3 and K2 are paired.Evidence: established physiology; EU authorised claim

⏱️ Long half-life of MK-7

MK-7 circulates for about three days, so a single daily dose maintains steady levels and reaches bone and vessel tissue more consistently than K1 or MK-4.Evidence: human pharmacokinetics (Schurgers 2007)

🧪 Arterial stiffness markers

Over three years, 180 µg MK-7 was associated with lower carotid-femoral pulse wave velocity and Stiffness Index β in postmenopausal women. These are surrogate measures, not events.Evidence: human RCT surrogate (Knapen 2015)

The Evidence

Vitamin K2 benefits: what the trials show

Most "vitamin K2 benefits" pages list bones, arteries, teeth and more without saying which were tested in people. Here is the evidence that actually exists, including the trials that found nothing.

244
postmenopausal women, 3-year MK-7 RCT (Knapen 2013)
~50%
fall in inactive osteocalcin and MGP with 180 µg MK-7 (Knapen 2013, 2015)
365
men in AVADEC: no calcification effect with 720 µg MK-7 + D (Circulation 2022)
1 in 4
Irish over-50s vitamin D deficient in winter (TILDA, Laird 2018)

Bone

RCT · 3 years · Positive

MK-7 180 µg/day slowed bone loss in postmenopausal women

Knapen and colleagues at VitaK, Maastricht University, randomised 244 healthy postmenopausal women aged 55 to 65 to 180 µg/day MK-7 or placebo for three years. MK-7 reduced the age-related decline in bone mineral content and bone mineral density at the lumbar spine and femoral neck (p=0.011 and p=0.012 at the femoral neck), but not at the total hip. Bone strength indices and loss of vertebral height in the lower thoracic spine were also favourably affected. Inactive (uncarboxylated) osteocalcin fell by about 50%.

Knapen MH et al. Osteoporos Int. 2013;24(9):2499-2507. PMID 23525894. PubMed

RCT · 1 year · Null

MK-7 360 µg/day did not change bone loss in early menopausal women

Emaus and colleagues in Norway randomised 334 healthy women aged 50 to 60, one to five years past menopause, to 360 µg/day MK-7 or placebo for one year. Vitamin K status improved, but there was no difference in bone mineral density loss at the hip or spine. The trial was shorter and the women younger than in the Maastricht study. The Knapen group noted their own differences only emerged after two to three years, but the Rønn trial below ran for three years and was also null.

Emaus N et al. Osteoporos Int. 2010;21(10):1731-1740. PMID 19937427. PubMed

RCT · 3 years · Null

MK-7 375 µg/day added to vitamin D and calcium did not improve bone density over three years

Rønn and colleagues at Aarhus University Hospital randomised 142 postmenopausal women with osteopenia to 375 µg/day MK-7 or placebo for three years, with both groups taking 38 µg vitamin D3 and 800 mg calcium daily. Inactive osteocalcin fell 65% with MK-7 at one year, but bone mineral density declined at all sites in both groups with no significant difference (total hip −1.5% vs −2.4%, p>0.09), and bone microarchitecture on HR-pQCT and trabecular bone score changed similarly in both groups. The biomarker improved; the bone did not. This is the most important counterweight to Knapen 2013.

Rønn SH et al. Osteoporos Int. 2021;32:185-191. PMID 33030563. PubMed

Meta-analysis · Pharmacological MK-4 · Fractures

Fracture data exist only for MK-4 at 45 mg/day in Japan

Cockayne et al. (University of York, Archives of Internal Medicine, 2006) pooled 13 randomised trials of vitamin K and bone. All seven trials reporting fractures were Japanese and used menaquinone-4 at pharmacological doses (45 mg/day), and pooled together they showed fewer vertebral (OR 0.40), hip (OR 0.23) and non-vertebral (OR 0.19) fractures. That dose is roughly 450 times the MK-7 content of a retail softgel and 1,000 times the MK-4 in a typical D3 + K2 capsule. No trial has measured fractures with MK-7 or with retail-dose MK-4, so these results cannot be transferred to supplements sold in Ireland.

Cockayne S et al. Arch Intern Med. 2006;166(12):1256-1261. PMID 16801507. PubMed

Arteries and the heart

RCT · 3 years · Surrogate markers

MK-7 180 µg/day reduced arterial stiffness measures

In the same 244-woman cohort, Knapen et al. (Thrombosis and Haemostasis, 2015) reported that MK-7 lowered inactive matrix Gla protein (dp-ucMGP) by 50% versus placebo, and that carotid-femoral pulse wave velocity and the Stiffness Index β decreased significantly in the total group, with local carotid improvements concentrated in women whose baseline Stiffness Index β was above the median of 10.8. These are measurements of vessel stiffness, not heart attacks or strokes.

Knapen MH et al. Thromb Haemost. 2015;113(5):1135-1144. PMID 25694037. PubMed

RCT · 2 years · Null

AVADEC: MK-7 plus vitamin D did not slow calcification

Diederichsen and colleagues at Odense University Hospital randomised 365 men aged 65 to 74 with existing aortic valve calcification to 720 µg/day MK-7 plus 25 µg vitamin D or placebo for 24 months. Aortic valve calcium score rose by 275 AU with treatment and 292 AU with placebo (difference −17 AU, 95% CI −86 to 53, p=0.64). Coronary calcification progression did not differ either. Adverse events were the same in both groups (9% vs 10%). The trial had no vitamin D-only arm, so it tests the combination against placebo, not the added value of K2 over D3. It was negative on its primary endpoint.

Diederichsen ACP et al. Circulation. 2022;145(18):1387-1397. PMID 35465686. PubMed

Observational · Association only

Higher dietary menaquinone intake linked to less coronary disease and calcification

The Rotterdam Study (Geleijnse et al., Journal of Nutrition, 2004) followed 4,807 Dutch adults and found those in the highest third of menaquinone intake, mostly from cheese, had lower coronary heart disease mortality and less severe aortic calcification than the lowest third. Beulens et al. (Atherosclerosis, 2009) found a similar inverse association with coronary calcification in 564 postmenopausal women. Vitamin K1 intake showed no such link in either study. These are associations in people eating cheese, not trials of supplements, and they are the origin of most K2 heart claims.

Geleijnse JM et al. J Nutr. 2004;134(11):3100-3105. PMID 15514282. PubMed · Beulens JW et al. Atherosclerosis. 2009;203(2):489-493. PMID 18722618. PubMed

Limitation

What the evidence does not cover

The positive long-term MK-7 trials discussed in this guide were conducted in postmenopausal women and measured bone density or vessel stiffness, not fractures or cardiovascular events. The two other long-term MK-7 bone trials (Rønn 2021, Emaus 2010) were null. There is no outcome trial of MK-7 in men, younger adults or people with normal vitamin K status. The 45 µg MK-4 dose found in most D3 + K2 capsules has no bone or vascular trial data at that dose. Anyone taking vitamin K2 should do so knowing these gaps.

Food Sources

Vitamin K2 foods

MK-7 intake from food is likely to be limited in diets that contain little or no natto, its richest dietary source, and natto, a Japanese fermented soybean dish, is almost absent from Irish shops and kitchens. The HSE lists vitamin K sources as green leafy vegetables, vegetable oils and cereal grains, with small amounts in meat and dairy; the vegetable sources are K1.[14]

In Dutch cohorts, cheese was the main dietary source of menaquinones, which is why the Rotterdam and Beulens studies could compare high and low intakes at all.[8] Egg yolk, butter and liver contribute MK-4. Kefir and sauerkraut are often listed online as K2 sources, but published values are low and variable and should not be relied on for intake.

Food Main vitamin K form Relative K2 content Realistic in an Irish diet?
Natto (fermented soybeans) K2 MK-7 Very high Rarely eaten
Hard and soft cheese K2 MK-8, MK-9 Moderate, varies by type Yes
Egg yolk, butter, liver K2 MK-4 Low to moderate Yes
Kefir, sauerkraut Mixed menaquinones Low, variable Yes
Kale, spinach, broccoli K1 only None (K1, not K2) Yes
Dosage

How much vitamin K2 to take with D3

There is no official Irish or EU recommended intake specific to vitamin K2. EFSA set an adequate intake of 70 µg/day for total vitamin K in adults (EFSA Journal, 2017) and declined to set an upper intake level because no adverse effects were identified.[12] The HSE puts the figure at about 1 µg per kilogram of body weight per day and says 1 mg or less from supplements is unlikely to cause harm.[14]

The trial doses are the useful reference. Theuwissen et al. (British Journal of Nutrition, 2012, PMID 22289649) tested MK-7 at 10, 20, 45, 90, 180 and 360 µg/day for 12 weeks in 42 healthy adults. Doses of 90 µg and above improved carboxylation of osteocalcin and matrix Gla protein; 45 µg and below did not reach significance. No dose affected thrombin generation.[7] The three-year bone and arterial trials used 180 µg/day.[1]

For vitamin D, the HSE position is the clearest guidance in Ireland: everyone needs a supplement. Adults aged 13 to 64 should take 15 µg (600 IU) daily from 31 October to 17 March, or all year if they have darker skin, limited sun exposure or are pregnant; adults aged 65 and over should take 15 µg daily all year round.[13] EFSA's tolerable upper intake level for adults is 100 µg (4,000 IU) per day.[11]

There is no evidence-based ratio of K2 to D3. The 1,000 IU D3 to 45 µg MK-4 pairing in many combination capsules reflects formulation convention, not a trial. The MK-7 trials discussed here used 90 to 375 µg/day, with the positive three-year bone trial using 180 µg/day. These are research doses, not an official Irish or EU recommended intake for K2, and they do not establish a personal dose for anyone. Vitamin K is fat-soluble, so trials gave it with food.

Weeks 0 to 12

Vitamin K status markers (carboxylated osteocalcin and MGP) improve within 12 weeks at 90 µg MK-7 and above (Theuwissen 2012). Nothing is felt; this is a blood measurement.

Year 1

In Knapen 2013 both the MK-7 and placebo groups lost bone at the femoral neck in year one with no separation yet. Emaus 2010 found no bone effect at one year with 360 µg/day.

Years 2 to 3

In Knapen 2013, differences in bone mineral density and vertebral height between MK-7 and placebo became significant at years two and three, and arterial stiffness differences appeared over the same period (Knapen 2015). In Rønn 2021, three years of 375 µg/day produced no bone density difference at all.

Beyond 3 years

No MK-7 trial data. Fracture and cardiovascular event effects have not been measured for MK-7 or for retail-dose MK-4.

Safety

Vitamin K2 side effects, warfarin and safety

Vitamin K2 has one of the cleaner safety records among supplements. EFSA found no adverse effects at any studied intake and did not set an upper level for vitamin K.[12] In AVADEC, two years of 720 µg/day MK-7 plus vitamin D produced the same adverse event rate as placebo, with no excess of severe bleeding, venous thromboembolism or cancer.[3] Theuwissen et al. found no effect on thrombin generation at up to 360 µg/day.[7]

A common search is "can vitamin K2 cause blood clots". In people not on anticoagulants, no increased clotting risk was detected in the cited trials: extra MK-7 did not change thrombin generation in Theuwissen 2012, and venous thromboembolism rates were the same as placebo in AVADEC. Those findings apply to the doses and populations studied; they do not rule out every possible risk for every person.

Warfarin and Vitamin K Antagonists

Warfarin works by blocking the recycling of vitamin K. Any vitamin K supplement, including K2 in a D3 + K2 capsule, reduces its anticoagulant effect. Schurgers et al. (Blood, 2007) showed MK-7 interfered with warfarin anticoagulation at lower doses than K1 because of its long half-life.[5] If you take warfarin or another vitamin K antagonist in Ireland, do not start vitamin K2 without agreement from your GP, anticoagulation clinic or pharmacist. Direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban) do not act through vitamin K, but check with your prescriber regardless.

Vitamin D Cautions

Keep total vitamin D from all supplements under the EFSA tolerable upper intake level of 100 µg (4,000 IU) per day unless a doctor has advised otherwise. High-strength products such as the Life Extension 5,000 IU formula also contain 1,000 µg iodine and should not be used by people with thyroid conditions without medical advice. Vitamin D supplements are not suitable for people with high blood calcium levels or certain granulomatous conditions; ask your GP if unsure.

Ireland

Vitamin K2 in Ireland: HSE advice, FSAI status, VAT

Ireland has a specific reason for the winter D3 + K2 habit. The Irish Longitudinal Study on Ageing (Laird et al., Journal of Gerontology, 2018, PMID 28958047) found one in eight adults over 50 were vitamin D deficient (below 30 nmol/L) overall, rising to one in four in winter and to 37% of those over 80 in winter.[10] That is why the HSE now advises people aged 13 to 64 to take 15 µg vitamin D daily between Halloween and St Patrick's Day, year-round for specified groups, and adults aged 65 and over to take it all year.[13]

There is no equivalent Irish deficiency data or public health advice for vitamin K2. The HSE position on vitamin K is simply that most people get enough from food and that supplements at 1 mg/day or less are unlikely to cause harm.[14] K2 in Ireland is therefore a personal choice based on the postmenopausal bone evidence, not a public health recommendation.

Regulatory Status in Ireland

Legal status: Vitamin K2 (as menaquinone-7 and menaquinone-4) and vitamin D3 (cholecalciferol) are permitted vitamin forms for food supplements across the EU. Products are sold in Ireland as food supplements under FSAI oversight, not as medicines, and are not assessed by the HPRA.[17]

Authorised claims: Under Regulation (EU) 432/2012, vitamin K contributes to normal blood clotting and to the maintenance of normal bones. Vitamin D contributes to normal absorption and utilisation of calcium and phosphorus, normal blood calcium levels, the maintenance of normal bones, teeth and muscle function, and normal function of the immune system. No claim about arteries, calcification or heart health is authorised for either vitamin.[15]

VAT: Food supplements in Ireland are charged at the 13.5% reduced VAT rate, confirmed in the Revenue Tax and Duty Manual on food supplement products.[16]

Customs: Orders shipped from within Ireland carry no customs duty or import handling fees. Since 1 November 2026, non-EU parcels face a €3 duty and €2 handling fee, covered in our iHerb customs charges guide.

Buyer's Guide

How to choose a vitamin K2 or D3 + K2 supplement in Ireland

Four questions settle most purchases.

1. Which K2 form? If you want the form with long-term trial data, choose MK-7 at 90 to 180 µg. MK-4 at 45 µg is the form in most D3 + K2 combination capsules; it is a legitimate vitamin K source and carries the same authorised claims, but it has no bone or vascular trial data at that dose and is poorly detected in serum.[6]

2. Separate or combined? A combined capsule is convenient for a winter routine at the HSE vitamin D level. Separate products let you set the D3 dose independently and use an MK-7 dose that matches the trials. If you already take a vitamin D3 product from our vitamin D3 range, adding a standalone MK-7 is the simplest route.

3. Capsule type. Healthy Origins uses a vegetarian (tapioca) softgel with beeswax, NOW uses a hypromellose veg capsule, Jarrow uses bovine gelatin. Vegans should note the beeswax in Healthy Origins and the gelatin in Jarrow.

4. Other supplements you take. Vitamin D works alongside magnesium and calcium in bone, and magnesium is the mineral Irish adults most often ask about next; see which magnesium is best for the forms compared. Omega-3 and vitamin K2 are both fat-soluble and are often taken with the same meal; our omega-3 Ireland guide covers EPA and DHA dosing.

Product Vitamin K2 Vitamin D3 Capsule Pack Fits best when
Healthy Origins Vitamin K2 as MK-7 100 µg 100 µg MK-7 (natto) None Vegetarian softgel, olive oil base 180 (6 months) You want MK-7 in the largest pack, six months per bottle
Jarrow Formulas Vitamin K2 MK-7 90 µg 90 µg MK-7 (VitaMK7®) None Bovine gelatin softgel 60 (2 months) You want to trial MK-7 before committing to a large pack
NOW Vitamin D3 & K2 1,000 IU / 45 µg 45 µg MK-4 25 µg (1,000 IU) Hypromellose veg capsule 120 (4 months at 1/day) You want one winter capsule near the HSE vitamin D level; accept low-dose MK-4
Life Extension Vitamins D and K with Sea-Iodine 100 µg MK-7 + 1,000 µg MK-4 + 1,000 µg K1 125 µg (5,000 IU) Vegetable cellulose capsule 60 (2 months) A clinician has advised high-dose D3; not for thyroid conditions or anticoagulant users
Product Details Verified

Product details on this page were verified by Probiotic.ie against the live Shopify listings on 5 November 2026: Healthy Origins Vitamin K2 as MK-7 100 µg (180 softgels, SKU HO-0020, menaquinone-7 from natto in organic extra virgin olive oil, vegetarian tapioca softgel); Jarrow Formulas Vitamin K2 MK-7 90 µg (60 softgels, SKU P25441, VitaMK7® from Bacillus subtilis natto, bovine gelatin softgel); NOW Vitamin D3 & K2 (120 veg capsules, SKU NOW-0720, 25 µg / 1,000 IU D3 plus 45 µg K2 as MK-4, hypromellose capsule); Life Extension Vitamins D and K with Sea-Iodine (60 capsules, SKU P34776, 125 µg D3, 2,100 µg total vitamin K, 1,000 µg iodine). Current prices, inclusive of 13.5% VAT, are shown on each product page. Always check the label on the pack you receive, as formulations change.

Research Context — Not Product Claims

The clinical and mechanistic research discussed in this article relates to vitamin K2 (MK-7) and vitamin D3 as studied compounds. It should not be read as a claim that Healthy Origins Vitamin K2 MK-7, Jarrow Formulas MK-7, NOW Vitamin D3 & K2 or Life Extension Vitamins D and K produce these effects. These products are food supplements, not medicines. No health claim beyond the authorised EU claims for vitamin K and vitamin D is made on this page or on the products.

Vitamin K2 MK-7 and D3 + K2 · Delivered from Dublin

Healthy Origins MK-7 100 µg, Jarrow Formulas MK-7 90 µg, NOW D3 & K2 and Life Extension D and K, all stocked in Dublin and shipped with tracked delivery across Ireland. No customs charges.

MK-7 from natto D3 + K2 combinations Ships from Dublin No customs fees Authorised Irish retailer
✓ Shop Vitamin K2 MK-7 in Ireland →

Food supplements, not medicines. Prices on product pages include 13.5% VAT. Free delivery in Ireland on orders over €75. Probiotic.ie is an authorised Irish retailer of Healthy Origins, Jarrow Formulas, NOW Foods and Life Extension.

Questions

Frequently asked questions

What is vitamin K2 and how is it different from vitamin K1?

Vitamin K2 is the menaquinone family of vitamin K, found in fermented foods such as natto and cheese and in some animal foods, while vitamin K1 (phylloquinone) comes mainly from green leafy vegetables. Both support the same vitamin K-dependent proteins, but Schurgers et al. (Maastricht University, Blood, 2007, PMID 17158229) showed the long-chain K2 form menaquinone-7 (MK-7) stays in the blood for days rather than hours and raises the activation of bone and vascular proteins more efficiently than the same dose of K1. The HSE lists vitamin K as needed for normal blood clotting and notes some evidence for bone health.

Do I need to take vitamin K2 with vitamin D3?

You do not have to. Vitamin D3 and vitamin K2 each have their own authorised EU health claims (vitamin D for normal calcium absorption and normal bones; vitamin K for normal blood clotting and normal bones) and each works whether or not the other is taken. The pairing rationale is mechanistic: vitamin D increases calcium absorption and vitamin K activates osteocalcin, which binds calcium in bone, and matrix Gla protein, which is proposed to limit calcium deposits in soft tissue. A large trial of the combination, AVADEC (Diederichsen et al., Circulation, 2022, PMID 35465686), found that 720 µg MK-7 plus 25 µg vitamin D for two years did not slow calcification progression versus placebo; it had no vitamin D-only arm, so the added benefit of K2 over vitamin D alone remains untested in humans.

What are the benefits of vitamin K2 according to clinical trials?

The strongest human evidence is for bone in postmenopausal women. Knapen et al. (Maastricht University, Osteoporosis International, 2013, PMID 23525894) gave 244 healthy postmenopausal women 180 µg/day of MK-7 or placebo for three years and found MK-7 reduced the age-related decline in bone mineral density at the lumbar spine and femoral neck, but not at the total hip. The same group (Thrombosis and Haemostasis, 2015, PMID 25694037) reported reduced arterial stiffness markers over three years. The evidence is mixed: Rønn et al. (Osteoporosis International, 2021, PMID 33030563) found 375 µg/day MK-7 for three years did not improve bone density in 142 women with osteopenia, and Emaus et al. (Osteoporosis International, 2010, PMID 19937427) found 360 µg/day for one year had no effect in early menopausal women. No MK-7 trial has measured fractures or cardiovascular events.

What is the difference between vitamin K2 MK-4 and MK-7?

MK-4 and MK-7 are both vitamin K2 but behave differently in the body. Sato et al. (Nutrition Journal, 2012, PMID 23140417) found a single 420 µg dose of MK-4 was not detectable in serum, while MK-7 at the same dose was well absorbed and raised serum levels, and Schurgers et al. (Blood, 2007, PMID 17158229) reported a half-life of about three days for MK-7 compared with hours for K1. The MK-7 trials that showed bone effects used 180 µg/day; the MK-4 bone studies used pharmacological doses of 45 mg/day in Japan, about a thousand times higher than the 45 µg found in typical D3 + K2 capsules. Low-dose MK-4 is therefore the least studied supplement form.

How much vitamin K2 should I take with D3?

Human trials of MK-7 used 90 to 375 µg per day, and the positive three-year bone and arterial trials used 180 µg per day; these are research doses, not an official Irish or EU recommended intake for K2. Theuwissen et al. (British Journal of Nutrition, 2012, PMID 22289649) found MK-7 doses of 90 µg and above improved vitamin K status markers within 12 weeks, with no effect on clotting measures in healthy adults. For vitamin D, the HSE advises people aged 13 to 64 in Ireland to take 15 µg (600 IU) daily from 31 October to 17 March, year-round for specified groups, and adults aged 65 and over to take 15 µg daily all year. EFSA's tolerable upper intake level for vitamin D is 100 µg (4,000 IU) per day for adults, a ceiling rather than a target. There is no fixed required ratio of K2 to D3.

What are the side effects of vitamin K2?

Vitamin K2 at supplement doses is well tolerated in trials. The HSE states that taking 1 mg (1,000 µg) or less of vitamin K supplements a day is unlikely to cause harm, and EFSA has not set an upper intake level for vitamin K because no adverse effects have been identified at dietary and supplemental intakes. The AVADEC trial (Circulation, 2022, PMID 35465686) found adverse event rates with 720 µg/day MK-7 plus vitamin D were the same as placebo over two years. The important exception is people taking vitamin K antagonist anticoagulants such as warfarin, where vitamin K2 directly opposes the medicine and must not be started without medical advice.

Can you take vitamin K2 if you are on warfarin or blood thinners?

Not without your prescriber's agreement. Warfarin works by blocking vitamin K recycling, so added vitamin K2 lowers its effect. Schurgers et al. (Blood, 2007, PMID 17158229) showed that MK-7 interfered with anticoagulation at lower doses than vitamin K1 because of its long half-life. Anyone on warfarin or another vitamin K antagonist in Ireland should speak to their GP, anticoagulation clinic or pharmacist before taking any vitamin K supplement, including D3 + K2 combinations. Direct oral anticoagulants such as apixaban and rivaroxaban do not work through vitamin K, but you should still check with your prescriber.

Which foods are high in vitamin K2?

Natto (fermented soybeans) is by far the richest food source of vitamin K2, specifically MK-7. Hard and soft cheeses, egg yolk, butter, liver and other animal foods provide smaller amounts, mostly as MK-4 and longer-chain menaquinones. In the Rotterdam Study (Geleijnse et al., Journal of Nutrition, 2004, PMID 15514282), cheese was the main source of menaquinone in the Dutch diet. Green leafy vegetables supply vitamin K1, not K2. A typical Irish diet is low in natto and so provides little MK-7.

Yes. Vitamin K2 as menaquinone-7 and menaquinone-4 is a permitted vitamin form in food supplements across the EU, and products containing it are sold in Ireland as food supplements under FSAI (Food Safety Authority of Ireland) oversight, not as medicines. Two authorised EU health claims apply to vitamin K under Regulation (EU) 432/2012: it contributes to normal blood clotting and to the maintenance of normal bones. Food supplements in Ireland carry 13.5% VAT, confirmed in the Revenue Tax and Duty Manual on food supplement products.

Does vitamin K2 reverse calcification of the arteries?

No human trial has shown that. The idea comes from observational studies: the Rotterdam Study (Geleijnse et al., 2004, PMID 15514282) and Beulens et al. (Atherosclerosis, 2009, PMID 18722618) found higher dietary menaquinone intake was associated with less coronary calcification and lower coronary heart disease risk, but association is not cause. The largest randomised test, AVADEC (Diederichsen et al., Circulation, 2022, PMID 35465686), gave 365 men with existing aortic valve calcification 720 µg MK-7 plus vitamin D for two years and found no significant difference in valve or coronary calcification progression versus placebo. Vitamin K2 should not be taken on the expectation of reversing existing calcification.

How long does vitamin K2 take to work?

Blood markers of vitamin K status change within weeks: Theuwissen et al. (British Journal of Nutrition, 2012, PMID 22289649) saw improved carboxylation of osteocalcin and matrix Gla protein within 12 weeks at 90 µg MK-7 and above. Measurable bone outcomes take far longer. In the three-year Knapen trial (Osteoporosis International, 2013, PMID 23525894), both groups lost bone in year one and the difference between MK-7 and placebo only became significant after two to three years, but a second three-year trial (Rønn et al., 2021, PMID 33030563) found no bone density difference at any point. One-year trials, including Emaus et al. (2010, PMID 19937427), found no bone effect.

Where can I buy vitamin K2 and D3 + K2 supplements in Ireland?

Probiotic.ie, a Dublin-based Irish retailer, stocks Healthy Origins Vitamin K2 as MK-7 100 µg (180 softgels, from natto), Jarrow Formulas Vitamin K2 MK-7 90 µg (60 softgels, VitaMK7), NOW Vitamin D3 & K2 1,000 IU / 45 µg MK-4 (120 veg capsules) and Life Extension Vitamins D and K with Sea-Iodine, all shipped from Dublin with tracked nationwide delivery across Ireland. Because orders ship from within Ireland, there are no customs or import charges. Vitamin K2 is also sold by Irish pharmacies and health stores. All are food supplements regulated under FSAI guidelines with 13.5% VAT.

Key Facts — Vitamin K2 and D3 + K2 Ireland
  • Vitamin K2 is the menaquinone family of vitamin K; MK-7 (from natto) and MK-4 are the forms used in supplements, and they are not interchangeable at the same microgram dose.
  • Vitamin K2 is not a treatment for osteoporosis or arterial calcification; no MK-7 trial has measured fractures or heart attacks, and the only fracture data come from pharmacological MK-4 (45 mg/day) trials in Japan.
  • EFSA set an adequate intake of 70 µg/day for vitamin K in adults (EFSA Journal, 2017) and no upper intake level; the HSE says 1 mg/day or less from supplements is unlikely to cause harm.
  • Most human MK-7 trials use 90 to 375 µg/day. Human evidence for bone density in postmenopausal women is mixed (Knapen 2013 positive; Rønn 2021 and Emaus 2010 null); for cardiovascular outcomes it is absent.
  • The strongest human evidence signal is reduced bone loss at the spine and femoral neck with 180 µg/day MK-7 over three years (Knapen et al., Osteoporosis International, 2013, PMID 23525894).
  • MK-7 has a half-life of about three days against hours for vitamin K1 (Schurgers et al., Blood, 2007, PMID 17158229); MK-4 was undetectable in serum after a 420 µg dose (Sato et al., Nutrition Journal, 2012, PMID 23140417).
  • The AVADEC trial (Diederichsen et al., Circulation, 2022, PMID 35465686) found 720 µg MK-7 plus 25 µg vitamin D for two years did not slow aortic valve or coronary calcification.
  • Observational links between dietary menaquinone and lower coronary disease (Rotterdam Study, 2004; Beulens 2009) are associations in people eating cheese and do not establish that supplements prevent heart disease.
  • The HSE advises people aged 13 to 64 in Ireland to take 15 µg (600 IU) vitamin D daily from 31 October to 17 March, year-round for specified groups, and adults aged 65 and over all year; EFSA's tolerable upper intake level is 100 µg (4,000 IU)/day.
  • Vitamin K2 opposes warfarin and other vitamin K antagonists and should not be started on these medicines without medical advice.
  • In Ireland, vitamin K2 and D3 + K2 products are regulated by the FSAI as food supplements, not medicines, and carry 13.5% VAT.
  • Healthy Origins Vitamin K2 MK-7 100 µg, Jarrow Formulas MK-7 90 µg, NOW Vitamin D3 & K2 and Life Extension Vitamins D and K are available from Probiotic.ie with tracked delivery from Dublin across Ireland.

Related guides

How We Reviewed This Guide

This guide was prepared by Probiotic.ie using the following process:

  • Reviewed the primary clinical sources: the Knapen 2013 and 2015 three-year MK-7 trials, the Rønn 2021 three-year MK-7 trial, the Emaus 2010 one-year trial, the AVADEC 2022 combination trial, the Cockayne 2006 fracture meta-analysis, the Theuwissen 2012 dose-finding study, the Sato 2012 and Schurgers 2007 bioavailability studies, and the Rotterdam and Beulens observational cohorts.
  • Included the negative and null trials alongside the positive ones, and separated surrogate markers (bone density, vessel stiffness, calcium scores) from clinical outcomes (fractures, cardiovascular events), which no trial has measured.
  • Verified every PMID and DOI against PubMed records via Europe PMC, Crossref and Semantic Scholar before publishing.
  • Checked HSE vitamin D and vitamin K guidance, EFSA dietary reference and upper intake level opinions, the Regulation (EU) 432/2012 authorised claims list, FSAI food-supplement rules and the Revenue VAT manual for Irish compliance.
  • Verified Healthy Origins, Jarrow Formulas, NOW Foods and Life Extension product details (form, dose, capsule type, pack size, SKU) against the live Probiotic.ie listings on 5 November 2026.
  • Submitted the draft to two independent AI audit engines before publication and corrected the evidence narrative where they identified omissions (the Rønn 2021 null trial, the MK-4 fracture literature) and over-statements.
  • Made no disease-treatment claims for any supplement and used only the authorised EU health claims for vitamin K and vitamin D.
DG
Darren Grant — Managing Director, Probiotic.ie

Darren Grant is Managing Director of TenX Tech Ltd, which operates Probiotic.ie and Probiotic.co.uk and is the sole authorised distributor of CDS22-formula in Ireland and the UK. He writes the evidence guides on this site, working to FSAI food supplement rules and the EU authorised health claims register, and verifies every citation and product detail before publication.

This guide is for educational purposes only and does not constitute medical advice. Healthy Origins Vitamin K2 MK-7, Jarrow Formulas Vitamin K2 MK-7, NOW Vitamin D3 & K2 and Life Extension Vitamins D and K with Sea-Iodine are food supplements regulated under FSAI guidelines and are not medicines; they are not intended to diagnose, treat, cure or prevent any disease or medical condition. If you take anticoagulant medication, have a thyroid condition, high blood calcium, or persistent or worsening symptoms, consult your GP or pharmacist before use. Probiotic.ie is regulated under FSAI food supplement guidelines.

Sources

  1. Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-2507. PMID 23525894. — pubmed.ncbi.nlm.nih.gov/23525894
  2. Knapen MH, Braam LA, Drummen NE, Bekers O, Hoeks AP, Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial. Thromb Haemost. 2015;113(5):1135-1144. PMID 25694037. — pubmed.ncbi.nlm.nih.gov/25694037
  3. Diederichsen ACP, Lindholt JS, Möller S, et al. Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial. Circulation. 2022;145(18):1387-1397. PMID 35465686. — pubmed.ncbi.nlm.nih.gov/35465686
  4. Emaus N, Gjesdal CG, Almås B, et al. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporos Int. 2010;21(10):1731-1740. PMID 19937427. — pubmed.ncbi.nlm.nih.gov/19937427
  5. Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109(8):3279-3283. PMID 17158229. — pubmed.ncbi.nlm.nih.gov/17158229
  6. Sato T, et al. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J. 2012;11:93. PMID 23140417. — pubmed.ncbi.nlm.nih.gov/23140417
  7. Theuwissen E, Cranenburg EC, Knapen MH, et al. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr. 2012;108(9):1652-1657. PMID 22289649. — pubmed.ncbi.nlm.nih.gov/22289649
  8. Geleijnse JM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100-3105. PMID 15514282. — pubmed.ncbi.nlm.nih.gov/15514282
  9. Beulens JW, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203(2):489-493. PMID 18722618. — pubmed.ncbi.nlm.nih.gov/18722618
  10. Laird E, et al. The prevalence of vitamin D deficiency and the determinants of 25(OH)D concentration in older Irish adults: data from The Irish Longitudinal Study on Ageing (TILDA). J Gerontol A Biol Sci Med Sci. 2018;73(4):519-525. PMID 28958047. — pubmed.ncbi.nlm.nih.gov/28958047
  11. EFSA Panel on Nutrition, Novel Foods and Food Allergens. Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate. EFSA Journal. 2023;21(8):8145. — doi.org/10.2903/j.efsa.2023.8145
  12. EFSA Panel on Dietetic Products, Nutrition and Allergies. Dietary reference values for vitamin K. EFSA Journal. 2017;15(5):4780. — doi.org/10.2903/j.efsa.2017.4780
  13. Health Service Executive (HSE). Vitamin D. — www2.hse.ie/conditions/vitamins-and-minerals/vitamin-d
  14. Health Service Executive (HSE). Vitamin K. — www2.hse.ie/conditions/vitamins-and-minerals/vitamin-k
  15. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health. — eur-lex.europa.eu CELEX:32012R0432
  16. Revenue Commissioners. Tax and Duty Manual: Food supplement products (VAT treatment). — revenue.ie food supplement products TDM
  17. Food Safety Authority of Ireland (FSAI). Food supplements legislation. — fsai.ie/legislation/food-legislation/food-supplements
  18. Rønn SH, Harsløf T, Oei L, et al. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial. Osteoporos Int. 2021;32:185-191. PMID 33030563. — pubmed.ncbi.nlm.nih.gov/33030563
  19. Cockayne S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166(12):1256-1261. PMID 16801507. — pubmed.ncbi.nlm.nih.gov/16801507

← →